UCLA Health launches telehealth genitourinary cancer genetics program

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

UCLA Health and the Department of Urology at UCLA have created a new telehealth cancer genetics program that will provide rapid access to high-quality genetic counseling and testing.

The program, which officially launches June 29, 2020, will focus on diagnosing hereditary kidney, bladder, testicular and prostate cancers. The program hopes to complement and expand on the work providers at the UCLA Jonsson Comprehensive Cancer Center have already developed.

There is a national shortage of genetic counselors, potentially impacting clinical outcomes of those who are diagnosed. In partnership with Genome Medical, this service will augment current efforts of UCLA genetic counselors to keep up with the rapid increase in new criteria for genetic testing.

Table of Contents

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login